Page last updated: 2024-08-17

isatin and selegiline

isatin has been researched along with selegiline in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (12.00)18.2507
2000's4 (16.00)29.6817
2010's18 (72.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Toprakçí, M; Yelekçi, K1
Bizzarri, B; Bolasco, A; Carradori, S; Chimenti, F; Chimenti, P; Granese, A; Orallo, F; Secci, D; Yáñez, M1
Alcaro, S; Bolasco, A; Cardia, MC; Carradori, S; Chimenti, F; Chimenti, P; Cirilli, R; Distinto, S; Ferretti, R; Granese, A; Kirchmair, J; Langer, T; Maccioni, E; Orallo, F; Ortuso, F; Secci, D; Yáñez, M1
Alcaro, S; Bolasco, A; Carradori, S; Chimenti, F; Chimenti, P; Granese, A; Orallo, F; Ortuso, F; Secci, D; Yáñez, M1
Bolasco, A; Carradori, S; Chimenti, F; Chimenti, P; Cirilli, R; Gallinella, B; Granese, A; Orallo, F; Sanna, ML; Secci, D; Yáñez, M1
Alcaro, S; Bolasco, A; Fioravanti, R; Manna, F; Orallo, F; Ortuso, F; Rossi, F; Vitali, A; Yáñez, M1
Alcaro, S; Borges, F; Gaspar, A; Orallo, F; Ortuso, F; Silva, T; Uriarte, E; Vina, D; Yáñez, M1
Alcaro, S; Bolasco, A; Carradori, S; Chimenti, P; Ortuso, F; Secci, D; Yáñez, M1
Bolasco, A; Carradori, S; D'Ascenzio, M; Nescatelli, R; Secci, D; Yáñez, M1
Alcaro, S; Biava, M; Desideri, N; Fioravanti, R; Ortuso, F; Proietti Monaco, L; Yáñez, M2
Agostinelli, E; Bonaiuto, E; Cozza, G; Di Paolo, ML; Fimognari, C; Hrelia, P; Marchetti, C; Milelli, A; Minarini, A; Tumiatti, V1
Alcaro, S; Carradori, S; Cirilli, R; D'Ascenzio, M; De Monte, C; Mannina, L; Ortuso, F; Secci, D; Sobolev, AP; Yáñez, M1
Estrada, M; Hripcsak, G; Matos, MJ; Rodríguez-Enríquez, F; Rodríguez-Franco, MI; Santana, L; Uriarte, E; Vilar, S; Viña, D1
Besada, P; Borges, F; Costas-Lago, MC; Rodríguez-Enríquez, F; Terán, C; Uriarte, E; Vilar, S; Viña, D1
Borges, F; Delogu, GL; Fontenla, JA; Hripcsak, G; Matos, MJ; Mayán, L; Munín, J; Pintus, F; Vilar, S; Viña, D1
Cheng, K; Duan, Y; Han, J; Huang, X; Kong, H; Li, S; Liao, C; Lv, X; Tian, Y; Xie, Z1
Clow, A; Dexter, D; Glover, V; Hussain, T; Sandler, M; Walker, M1
Richardson, JS1
Clow, A; Glover, V; Sandler, M1
Endo, T; Hamaue, N; Hirafuji, M; Hiroshige, T; Machida, M; Minami, M; Ogata, A; Parvez, SH; Saito, H; Tashiro, K; Terado, M1
Buneeva, O; Fedchenko, V; Glover, V; Gnedenko, O; Ivanov, Y; Medvedev, A; Medvedeva, M; Sandler, M1
Buneeva, O; Fedchenko, V; Globa, A; Glover, V; Kaloshin, A; Kapitsa, I; Medvedev, A; Nerobkova, L; Val'dman, E1
Buneeva, OA; Kopylov, AT; Medvedev, AE; Zgoda, VG1
Buneeva, OA; Ivanova, EA; Kapitsa, IG; Kopylov, AT; Medvedev, AE; Zgoda, VG1

Reviews

2 review(s) available for isatin and selegiline

ArticleYear
On the functions of monoamine oxidase, the emotions, and adaptation to stress.
    The International journal of neuroscience, 1993, Volume: 70, Issue:1-2

    Topics: Adaptation, Psychological; Depressive Disorder; Emotions; Humans; Hypothalamus; Isatin; Limbic System; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Selegiline; Stress Disorders, Post-Traumatic; Stress, Psychological

1993
Effects of dopaminergic drugs on superoxide dismutase: implications for senescence.
    Journal of neural transmission. Supplementum, 1993, Volume: 40

    Topics: Aging; Animals; Corpus Striatum; Enzyme Induction; Free Radicals; Humans; Isatin; Life Expectancy; Nerve Degeneration; Parkinson Disease; Pergolide; Rats; Selegiline; Substantia Nigra; Superoxide Dismutase

1993

Other Studies

23 other study(ies) available for isatin and selegiline

ArticleYear
Docking studies on monoamine oxidase-B inhibitors: estimation of inhibition constants (K(i)) of a series of experimentally tested compounds.
    Bioorganic & medicinal chemistry letters, 2005, Oct-15, Volume: 15, Issue:20

    Topics: Crystallography, X-Ray; Kinetics; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors

2005
Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:2

    Topics: Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pyrazoles

2010
Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors.
    Bioorganic & medicinal chemistry, 2010, Jul-15, Volume: 18, Issue:14

    Topics: Chromatography, High Pressure Liquid; Humans; Hydrazones; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship; Thiazoles

2010
Investigations on the 2-thiazolylhydrazyne scaffold: synthesis and molecular modeling of selective human monoamine oxidase inhibitors.
    Bioorganic & medicinal chemistry, 2010, Aug-01, Volume: 18, Issue:15

    Topics: Humans; Hydrazines; Hydrogen Peroxide; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship

2010
Synthesis, stereochemical separation, and biological evaluation of selective inhibitors of human MAO-B: 1-(4-arylthiazol-2-yl)-2-(3-methylcyclohexylidene)hydrazines.
    Journal of medicinal chemistry, 2010, Sep-09, Volume: 53, Issue:17

    Topics: Chromatography, High Pressure Liquid; Cyclohexanes; Humans; Hydrazines; Isoenzymes; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Triazoles

2010
Synthesis and molecular modelling studies of prenylated pyrazolines as MAO-B inhibitors.
    Bioorganic & medicinal chemistry letters, 2010, Nov-15, Volume: 20, Issue:22

    Topics: Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Prenylation; Pyrazoles; Structure-Activity Relationship

2010
Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors.
    Journal of medicinal chemistry, 2011, Jul-28, Volume: 54, Issue:14

    Topics: Amides; Chromones; Humans; Isoenzymes; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship; Water

2011
Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:10

    Topics: Coumarins; Humans; Inhibitory Concentration 50; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship

2011
Recent advances in the development of selective human MAO-B inhibitors: (hetero)arylidene-(4-substituted-thiazol-2-yl)hydrazines.
    European journal of medicinal chemistry, 2012, Volume: 58

    Topics: Dose-Response Relationship, Drug; Humans; Hydrazines; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Structure-Activity Relationship

2012
1,5-Diphenylpenta-2,4-dien-1-ones as potent and selective monoamine oxidase-B inhibitors.
    European journal of medicinal chemistry, 2013, Volume: 59

    Topics: Cells, Cultured; Curcumin; Enzyme Activation; Humans; Inhibitory Concentration 50; Models, Molecular; Monoamine Oxidase Inhibitors; Quantum Theory; Structure-Activity Relationship

2013
Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases.
    European journal of medicinal chemistry, 2013, Volume: 70

    Topics: Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Polyamines; Structure-Activity Relationship; Substrate Specificity

2013
Identification of the stereochemical requirements in the 4-aryl-2-cycloalkylidenhydrazinylthiazole scaffold for the design of selective human monoamine oxidase B inhibitors.
    Bioorganic & medicinal chemistry, 2014, May-15, Volume: 22, Issue:10

    Topics: Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Design; Humans; Isoenzymes; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Stereoisomerism; Structure-Activity Relationship; Thiazoles

2014
Potent and selective MAO-B inhibitory activity: amino- versus nitro-3-arylcoumarin derivatives.
    Bioorganic & medicinal chemistry letters, 2015, Feb-01, Volume: 25, Issue:3

    Topics: Binding Sites; Coumarins; Humans; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Binding; Protein Isoforms; Protein Structure, Tertiary; Selegiline; Structure-Activity Relationship

2015
(E)-3-Heteroarylidenechroman-4-ones as potent and selective monoamine oxidase-B inhibitors.
    European journal of medicinal chemistry, 2016, Jul-19, Volume: 117

    Topics: Chromans; Humans; Hydrogen Bonding; Inhibitory Concentration 50; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Sensitivity and Specificity; Solvents; Structure-Activity Relationship

2016
Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors.
    European journal of medicinal chemistry, 2017, Oct-20, Volume: 139

    Topics: Coumarins; Dose-Response Relationship, Drug; Humans; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Pyridazines; Structure-Activity Relationship

2017
MAO inhibitory activity of bromo-2-phenylbenzofurans: synthesis,
    MedChemComm, 2017, Sep-01, Volume: 8, Issue:9

    Topics:

2017
Design, synthesis and biological evaluation of novel human monoamine oxidase B inhibitors based on a fragment in an X-ray crystal structure.
    Bioorganic & medicinal chemistry letters, 2019, 04-15, Volume: 29, Issue:8

    Topics: Binding Sites; Catalytic Domain; Crystallography, X-Ray; Drug Design; Humans; Isatin; Molecular Dynamics Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Isoforms; Structure-Activity Relationship

2019
Pergolide can induce soluble superoxide dismutase in rat striata.
    Journal of neural transmission. General section, 1992, Volume: 90, Issue:1

    Topics: Animals; Brain Chemistry; Corpus Striatum; Cytosol; Dopamine; Enzyme Induction; Isatin; Levodopa; Male; Mitochondria; Pergolide; Rats; Rats, Wistar; Selegiline; Subcellular Fractions; Superoxide Dismutase

1992
Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus.
    Neurotoxicology, 2004, Volume: 25, Issue:1-2

    Topics: Animals; Disease Models, Animal; Dopamine; Encephalitis Virus, Japanese; Hypokinesia; Isatin; Mice; Monoamine Oxidase Inhibitors; Parkinson Disease; Rats; Selegiline

2004
Isatin interaction with glyceraldehyde-3-phosphate dehydrogenase, a putative target of neuroprotective drugs: partial agonism with deprenyl.
    Journal of neural transmission. Supplementum, 2006, Issue:71

    Topics: Animals; Biosensing Techniques; Dose-Response Relationship, Drug; Drug Interactions; Glyceraldehyde-3-Phosphate Dehydrogenases; Isatin; Monoamine Oxidase Inhibitors; Muscles; NAD; Protein Array Analysis; Protein Binding; Rabbits; Selegiline; Time Factors; Tritium

2006
The effect of short-term administration of (-)-deprenyl and isatin on the expressions of some genes in the mouse brain cortex.
    Medical science monitor : international medical journal of experimental and clinical research, 2008, Volume: 14, Issue:12

    Topics: Animals; Cerebral Cortex; Gene Expression Regulation; Glyceraldehyde-3-Phosphate Dehydrogenases; Isatin; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Polymerase Chain Reaction; Selegiline; Superoxide Dismutase

2008
[The effect of deprenyl and isatin administration to mice on the proteomic profile of liver isatin-binding proteins].
    Biomeditsinskaia khimiia, 2018, Volume: 64, Issue:4

    Topics: Animals; Binding, Competitive; Isatin; Ligands; Liver; Male; Metabolome; Mice, Inbred C57BL; Neuroprotective Agents; Protein Binding; Proteomics; Selegiline

2018
[The effect of a neuroprotective dose of isatin or deprenyl to mice on the profile of brain isatin-binding proteins].
    Biomeditsinskaia khimiia, 2019, Volume: 65, Issue:5

    Topics: Animals; Brain; Carrier Proteins; Isatin; Mice; Neuroprotective Agents; Proteomics; Selegiline

2019